Bora Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
May 13, 2020 at 08:20 am EDT
Share
Bora Pharmaceuticals Co., Ltd. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was TWD 372.603 million compared to TWD 380.451 million a year ago. Operating income was TWD 44.705 million compared to TWD 95.434 million a year ago. Net income was TWD 44.469 million compared to TWD 87.246 million a year ago. Basic earnings per share was TWD 1.1 compared to TWD 2.29 a year ago. Diluted earnings per share was TWD 1.09 compared to TWD 2.25 a year ago.
Bora Pharmaceuticals Co Ltd is a Taiwan-based company principally engaged in the agency and sales of western medicines, as well as the research, development, manufacture and sales of new drugs and health products. The Company's main products are categorized into prescription drugs and health care products, including central nervous drugs, cardiovascular drugs, antibiotics, antiviral agents, ophthalmic drugs, gastrointestinal drugs, foam ingots and health care products. In addition, the Company has biopharmaceutical technologies related to the development of cell lines for the production of protein drugs, the development and analysis of upstream and downstream processes, as well as the establishment of quality control and testing specifications and the creation of cell banks.
BORA PHARMACEUTICALS CO., LTD. 
